Creighton and colleagues reported in 2009 that a gene expression signature common to both CD44+/CD24−/low and mammosphere-forming cells was found mainly in human breast cancer of the recently identified claudin-low molecular subtype, which is characterized by expression of many EMT-associated genes. This evidence concerns the gene CD44 and breast cancer.